Pharmacyclics, LLC - An AbbVie Company


Pharmacyclics LLC, a wholly-owned subsidiary of AbbVie (NYSE: ABBV), is focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune-mediated diseases. Pharmacyclics’ mission is to develop and commercialize novel therapies intended to improve quality of life, increase duration of life, and resolve serious unmet medical needs. Pharmacyclics markets IMBRUVICA.

Exhibitor Level: 
Bronze Level
Booth Number: